Your browser doesn't support javascript.
loading
Competing endogenous RNA networks of CYP4Z1 and pseudogene CYP4Z2P confer tamoxifen resistance in breast cancer.
Zheng, Lufeng; Li, Xiaoman; Meng, Xia; Chou, Jinjiang; Hu, Jinhang; Zhang, Feng; Zhang, Zhiting; Xing, Yingying; Liu, Yu; Xi, Tao.
Afiliação
  • Zheng L; School of Life Science and Technology, China Pharmaceutical University, Nanjing 210009, PR China; Jiangsu Key Laboratory of Carcinogenesis and Intervention, China Pharmaceutical University, Nanjing 210009, PR China.
  • Li X; Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, PR China.
  • Meng X; School of Life Science and Technology, China Pharmaceutical University, Nanjing 210009, PR China; Jiangsu Key Laboratory of Carcinogenesis and Intervention, China Pharmaceutical University, Nanjing 210009, PR China.
  • Chou J; School of Life Science and Technology, China Pharmaceutical University, Nanjing 210009, PR China; Jiangsu Key Laboratory of Carcinogenesis and Intervention, China Pharmaceutical University, Nanjing 210009, PR China.
  • Hu J; School of Life Science and Technology, China Pharmaceutical University, Nanjing 210009, PR China; Jiangsu Key Laboratory of Carcinogenesis and Intervention, China Pharmaceutical University, Nanjing 210009, PR China.
  • Zhang F; School of Life Science and Technology, China Pharmaceutical University, Nanjing 210009, PR China; Jiangsu Key Laboratory of Carcinogenesis and Intervention, China Pharmaceutical University, Nanjing 210009, PR China.
  • Zhang Z; School of Life Science and Technology, China Pharmaceutical University, Nanjing 210009, PR China; Jiangsu Key Laboratory of Carcinogenesis and Intervention, China Pharmaceutical University, Nanjing 210009, PR China.
  • Xing Y; School of Life Science and Technology, China Pharmaceutical University, Nanjing 210009, PR China; Jiangsu Key Laboratory of Carcinogenesis and Intervention, China Pharmaceutical University, Nanjing 210009, PR China.
  • Liu Y; Department of Biochemistry, School of Life Science and Technology, China Pharmaceutical University, Nanjing 210009, PR China.
  • Xi T; School of Life Science and Technology, China Pharmaceutical University, Nanjing 210009, PR China; Jiangsu Key Laboratory of Carcinogenesis and Intervention, China Pharmaceutical University, Nanjing 210009, PR China. Electronic address: xitao18@hotmail.com.
Mol Cell Endocrinol ; 427: 133-42, 2016 May 15.
Article em En | MEDLINE | ID: mdl-26980484
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tamoxifeno / Neoplasias da Mama / RNA Neoplásico / Pseudogenes / Resistencia a Medicamentos Antineoplásicos / Antineoplásicos Hormonais / Família 4 do Citocromo P450 Limite: Female / Humans Idioma: En Revista: Mol Cell Endocrinol Ano de publicação: 2016 Tipo de documento: Article País de publicação: Irlanda
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tamoxifeno / Neoplasias da Mama / RNA Neoplásico / Pseudogenes / Resistencia a Medicamentos Antineoplásicos / Antineoplásicos Hormonais / Família 4 do Citocromo P450 Limite: Female / Humans Idioma: En Revista: Mol Cell Endocrinol Ano de publicação: 2016 Tipo de documento: Article País de publicação: Irlanda